ELK1 and cancer: miR-144 has been credited with multiple activities in cancer (both pro- and anti-oncogenic, depending on the cancer type), and its expression in SK-BR-3 cells was found to be regulated through GPER and the PI3K-MAPK/ELK1 axis [83].